Rangering i aksjer
#24990
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical... Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.
Aksjekurs
$3.95
Sist synkronisert: 2023-08-15
Handel Biostage, Inc. (BSTG)
Pris BSTG pris med markedsverdi på B
Markedsverdi av Biostage, Inc.(BSTG)
Markedsverdi: $54.45M
Per August 2026 har Biostage, Inc. en markedsverdi på $54.45M. Dette gjør Biostage, Inc. til det 24990th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Biostage, Inc. fra 2013 til 2026
BSTG sammenlignet med topp 5 mest populære stocks
| Pris på BSTG |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.257T
|
+9,653,437.22%
|
|
|
|
|
$4.599T
|
+8,444,737.94%
|
|
|
|
|
$4.107T
|
+7,541,116.23%
|
|
|
|
|
$3.577T
|
+6,569,069.58%
|
|
|
|
|
$2.807T
|
+5,155,158.20%
|
